desoximetasone


Also found in: Wikipedia.

desoximetasone

 [des-ok″se-met´a-sōn]
1. a steroid used topically to relieve inflammation and itching in corticosteroid-responsive dermatoses.
2. a synthetic corticosteroid used topically for the relief of inflammation and pruritus in corticosteroid-responsive dermatoses.

desoximetasone

/des·ox·i·met·a·sone/ (des-ok″se-met´ah-sōn) a synthetic corticosteroid used topically for the relief of inflammation and pruritus in corticosteroid-responsive dermatoses.

desoximetasone

(dĕs-ŏk′sē-mĕt′ə-sōn′)
n.
An anti-inflammatory corticosteroid containing fluorine and used in topical preparations.

desoximetasone

[desok′simet′əsōn]
a topical corticosteroid.
indication It is prescribed for the treatment of skin inflammation.
contraindications Viral and fungal diseases of the skin, impaired circulation, or known hypersensitivity to this drug or to other steroid medication prohibits its use. Caution should be used in applying occlusive dressings over topical steroid medications.
adverse effects Among the more serious adverse reactions, usually occurring after prolonged or excessive application, are striae, hypopigmentation, or local irritation of the skin and various systemic effects.

desoximetasone

(desok´sēmet´əsōn),
n brand names: Topicort, Topicort LP;
drug class: topical corticosteroid, group II potency (0.25%), group III potency (0.05%);
action: interacts with steroid cytoplasmic receptors to induce antiinflammatory effects;
uses: psoriasis, eczema, contact dermatitis, pruritus.

desoximetasone, desoxymethasone

an anti-inflammatory, antipruritic and vasoconstrictive corticosteroid used topically to relieve inflammation in corticosteroid-responsive dermatoses.
References in periodicals archive ?
Food and Drug Administration (FDA) an Abbreviated New Drug Application for desoximetasone topical spray 0.
Clocortolone cream is the hypoallergenic midpotency steroid of choice, whereas desoximetasone cream or ointment is the safest mid- to high-potency option, Dr.
Six-month controlled study of effect of desoximetasone and betamethasone 17-valerate on the pituitary-adrenal axis.
25% desoximetasone ointment applied twice daily for an average of 11 weeks.
The Company announced final approvals for desoximetasone gel, ciclopirox olamine cream, terconazole vaginal suppositories and a tentative approval for sertraline hydrochloride tablets during the quarter.
Food and Drug Administration for its ANDAs for Hydrocortisone Valerate Cream and Ointment, as well as line extensions such as Clobetasol Topical Solution and Desoximetasone Gel.